Regulated information
Waregem (Belgium)/Rotterdam (Netherlands)[1], 30 September 2015
Fagron announces today that there are no changes in the Guarantor List in accordance with the Guarantee Declaration dated 12 June 2012 regarding the € 225,000,000 4.75% Bond with maturity date 2 July 2017.
The list of Guarantors, in accordance with Article 10.4 of the Guarantee Declaration, is available at investors.fagron.com.
In accordance with Condition 10 (b) of the Bonds a new Compliance Certificate is published. This Compliance Certificate is available at investors.fagron.com.
For further information
Jan Peeters
Chief Financial Officer
Tel. +31 88 331 12 52
jan.peeters@fagron.com
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.
Fagron profile
Fagron is a scientific pharmaceutical R&D company that is focused on optimizing and innovating customized pharmaceutical care. Fagron provides Fagron Specialty Pharma Services, Fagron Trademarks and Fagron Essentials to pharmacies, clinics and hospitals in 32 countries worldwide.
The Belgian company Fagron NV is located in Waregem and is listed on Euronext Brussels and Euronext Amsterdam. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.
[1] This press release was sent out by Fagron NV and Fagron BV.
Please open the link below for the press release: